11:30 am – 12:30 pm Saturday, October 30

Stopping the Flow: Management of Heavy Menstrual Bleeding and Menstrual Concerns in Adolescent Females with Bleeding and Clotting Disorders (226)

Heavy menstrual bleeding (HMB) and dysmenorrhea are common complaints among adolescent females (O’Brien, 2018). For females with underlying bleeding and clotting disorders, managing their menstrual bleeding can provide challenges unique to their stages of life.

Read more...
Speaker:
Elizabeth Vessey, NP
CNE Hours
1
3:30 – 4:30 pm Friday, October 29

Paper Presentation: Long Term (or Chronic) Supportive Care — Long-term Anticoagulation in Children Utilizing Fondaparinux-A Single Pediatric Center Experience (222-3)

Fondaparinux is a synthetic, subcutaneously administered heparinoid that selectively inhibits activated factor X. Pediatric studies of fondaparinux have shown safety and efficacy profiles for the treatment of venous thromboembolism that was similar to standard pediatric anticoagulants.

Read more...
3:30 – 4:30 pm Friday, October 29

Paper Presentation: Long Term (or Chronic) Supportive Care — Individualized Pain Plans in Managing Pain in Patients with Sickle Cell Disease (222-2)

Vaso-occlusive crisis (VOC) is the leading cause of hospital admissions in pediatric patients with sickle cell disease (SCD). Achieving the maximum opioid dose earlier in the admission is associated with shorter lengths of stays, allowing children suffering from SCD to spend less time in the hospital and decreasing their risk for depression and other long-term hospital-associated complications.

Read more...
5:00 – 6:00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Do CSF Biomarkers Relate to Measures of Cognitive Function in Children During Maintenance Therapy for Leukemia? (210-3)

Children treated for acute lymphocytic leukemia (ALL) receive central nervous system–directed chemotherapy, which is a known risk factor for cognitive dysfunction. ALL chemotherapy treatment is also associated with changes in biomarkers of inflammation and oxidative stress, which may underlie changes in neurocognitive functioning.

Read more...
5:00 – 6:00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Analysis of AYA Cancer Patient Priority Symptoms Using Text Mining Software (210-2)

The symptoms associated with cancer treatment are a major concern for the adolescent and young adult (AYA) population. Understanding these distinct symptom experiences, especially AYAs' priority symptoms—those that take the forefront of a patient’s concern—can support healthcare providers in providing personalized care.

Read more...
Speaker:
Kylie Bethards
CNE Hours
1
5:00 – 6: 00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Qualitative Content Analysis of Daily Journaling by Children with Cancer Using a Game-Based App (210-1)

The consequences of cancer persist beyond the clinical setting. Resources to assess the child’s quality of life and markers of well-being outside of the clinical setting can support a more personalized approach to care. Color Me Healthy is a new, game-based symptom assessment app that was co-designed by children with cancer and pediatric oncology clinicians.

Read more...
Speaker:
Kaitlyn Fox, BSN RN
CNE Hours
1

Practical Workings of a Pediatric and Adolescent Fertility Preservation Program, from Consults to Care Models (003)

In recent years, there has been increased emphasis on fertility preservation (FP) in pediatric hematology/oncology centers. The growing population of cancer patients and patients receiving hematopoietic cell transplants (HCTs) for nonmalignant diseases (e.g., sickle cell disease) has resulted in more patients expressing interest in FP information and interventions at Children’s Healthcare of Atlanta (CHOA).

Read more...
Speaker:
James Ludemann, BSN RN OCN CPHON®

Megan Pruett, MSN CPNP

Fee
$110 for members
$140 for non-members
CNE Hours
3.25
Subscribe to this RSS feed